StockWatch
·
Q2 FY-2027 RESULTS · CHOLAFIN

Chola Q2 FY27: Consol PAT +41% YoY to ₹1,630 Cr on margin expansion, cools 2% QoQ

PAT +40.59% YoY · revenue +23.75% · margins expanding · beat vs street

Q2 FY27 resultsCHOLAFINCholamandalam Investment and Finance Company Ltd28 Oct 2026 · 3 min read
Revenue

₹9,270.92 Cr

+23.75% YoY

PAT (consolidated)

₹1,630.34 Cr

+40.59% YoY

Net margin

17.35%

+2.1pp YoY

EPS

₹19.09

Cholamandalam Investment and Finance reported consolidated PAT of ₹1,630.34 Cr for Q2 FY27, up 40.6% year-on-year from ₹1,159.61 Cr, on consolidated revenue of ₹9,270.92 Cr (+23.75% YoY). Profit growth outpaced revenue growth, pushing net profit margin to 17.36% from 15.23% a year ago (standalone NPM 17.63% vs 15.47%, per the regulatory ratio disclosure). Sequentially the picture is softer: revenue rose 4.68% QoQ but PAT slipped 1.56% QoQ from Q1 FY27's ₹1,656.22 Cr, and NPM compressed from Q1's 18.49% — a normal give-back after an unusually strong opening quarter rather than a trend reversal, and YoY remains the primary read per house convention. Standalone and consolidated results are effectively identical (PAT differs by just ₹0.27 Cr), so there is no basis divergence to flag.

The scoreboard

Q2 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹9,270.92 Cr+4.7%+23.8%
Expenses₹7,207.46 Cr+7%+19.2%
PAT₹1,630.34 Cr-1.56%+40.59%
Net margin17.35%-1.1pp+2.1pp
EPS₹19.09-1.7%+38.5%

The margin expansion sits on contained credit costs and improving asset quality rather than a one-off: impairment of financial instruments was ₹874.21 Cr, down from ₹922.06 Cr in Q1, while Gross Stage-3 (NPA) improved to 3.25% from 3.35% YoY and Net Stage-3 to 1.80% from 1.93% YoY, with provision coverage up to 45.32% from 43.23%. By segment, Vehicle Finance (PBT ₹979.17 Cr) and Loan Against Property (₹556.17 Cr) together drove the bulk of the ₹2,188.38 Cr segment PBT, with Home Loans contributing ₹269.02 Cr — consistent with the diversification thesis analysts have been tracking. The standalone loan book grew to ₹2,40,133.20 Cr from ₹2,17,571.16 Cr at FY26-end, a ~10.4% six-month rise that annualises close to the 23% FY27 AUM-growth guidance management gave on the Q1 concall; credit costs also look contained relative to the ~1.5% guided band, though the filing does not disclose a precise pre-tax ROA to check against the 3.5% minimum (Q1: 3.7%), so guidance delivery is assessed as broadly on-track rather than confirmed beat. No separate management press release was available in this filing to cross-check against the numbers.

₹
1,388.851,541.41,693.951,846.51,999.051,51807-2708-1809-0910-0510-28Q2 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹1,518, down 8.7% over the past month of trading.

₹ Cr
0618.321,236.641,854.971,259.54Q4 FY25rev ₹7,046 Cr1,137.83Q1 FY26rev ₹7,267 Cr1,159.61Q2 FY26rev ₹7,491 Cr1,645.2Q4 FY26rev ₹8,417 Cr1,656.22Q1 FY27rev ₹8,856 Cr1,630.34Q2 FY27rev ₹9,271 Cr
Quarterly consolidated PAT, ₹ Crore

For context: revenue is at a 6-quarter high.

What management guided (1 FY-2027 call)
FY27 AUM growth 23% likely (already achieved Q1), disbursements 22-23% growth, pre-tax ROA maintain 3.5% minimum (beat at 3.7% in Q1), credit costs hold ~1.5%. Cost of funds neutral for full year assuming 25-50 bps RBI rate hike.

— This quarter: met

Against our pre-result preview, which flagged Street expectations of ~₹8,900–9,100 Cr revenue and ~₹18.85 EPS for the quarter, the actual consolidated revenue of ₹9,270.92 Cr and basic EPS of ₹19.09 both came in above the expected range — a beat on both counts. Capital adequacy improved to 20.62% from 20.00% YoY even before the board's same-day approval of a QIP to raise up to ₹5,000 Cr, and the quarter also saw conversion of the remaining CCDs into 30.55 lakh equity shares and allotment of ₹2,000 Cr of perpetual NCDs — both consistent with the company funding its stated growth plan. The prior concall's cautious tone centered on cost-of-funds neutrality assuming a 25–50 bps RBI rate hike and holding credit costs near 1.5%; this quarter's contained impairment charge and improved NPA ratios are broadly consistent with that script.

  • W1

    QIP pricing/dilution terms for the up-to-₹5,000 Cr raise approved this quarter — impact on EPS and ROE to confirm next

  • W2

    Sequential NPM (18.49% Q1 → 17.36% Q2 consolidated) — confirm Q1 was the seasonal outlier, not a reversing trend

  • W3

    Credit cost trajectory against management's ~1.5% guided band, given this quarter's impairment charge of ₹874.21 Cr and loan book growth pace vs the 23% FY27 AUM target

Clean typed statement, columns unambiguous (30.09.2026 Audited vs 30.06.2026 Un-audited vs 30.09.2025 Audited); standalone and consolidated nearly identical (two small subsidiaries + one JV, Group PAT only ₹0.27 Cr above standalone) — no material basis divergence; no exceptional items in either P&L this quarter or year-ago; board also approved a ₹5,000 Cr QIP same day.

Informational and educational content only. Not investment advice.